PTEN and prostate cancer: Subsequent cell colony assays confirmed that the promotion of increased chemokine signalling was coupled to an adverse response of irradiated PTEN-deficient prostate cancer cells, and consequently, that the inhibition of this chemokine signalling pathway markedly increased the sensitivity of three distinct models of prostate carcinoma to IR.